Evaluation of the c-Met immunostain to detect malignant cells in body cavity effusions

Oncology Reports

Volumn 8, Issue 6, 2001, Pages 1347-1350

  Zimmerman, Robert L ^a   Fogt, Franz ^a  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; c Met; Cytology; Mesothelioma; Mesothelium; Serous effusions

Indexed keywords

BIOLOGICAL MARKER; SCATTER FACTOR RECEPTOR;

ADENOCARCINOMA; ARTICLE; CARCINOMA; CYTODIAGNOSIS; CYTOLOGY; ENZYME IMMUNOASSAY; EPITHELIUM; EXUDATE; HUMAN; MESOTHELIOMA; METABOLISM; METHODOLOGY; PATHOLOGY;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CARCINOMA; CYTODIAGNOSIS; EPITHELIUM; EXUDATES AND TRANSUDATES; HUMANS; IMMUNOENZYME TECHNIQUES; MESOTHELIOMA; PROTO-ONCOGENE PROTEINS C-MET;

EID: 0035514234     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.6.1347     Document Type: Article

References (27)

1. Queiroz C, Barral-Netto M and Bacchi CE: Characterizing sub-populations of neoplastic cells in serous effusions. The role of immunohistochemistry. Acta Cytol 45: 18-22, 2001.
2. Bedrossian CWM: Special stains, the old and the new: the impact of immunocytochemistry on effusion cytology. Diagn Cytopathol 18: 141-149, 1998.
3. Naylor B: Pleural, peritoneal and pericardial fluids. In: Diagnostic Cytopathology, 2nd edit., Bibbo M (Ed.). W.B. Saunders Co., Philadelphia, pp597-602, 1996.
4. Roberts F, Harper CM, Downie I and Burnett RA: Immuno-histochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. Am J Clin Pathol 116: 253-262, 2001.
5. Pindzola JA, Kovatich AJ and Bibbo M: p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma Acta Cytol 44: 31-36, 2000.
6. Gherardi E and Stoker M: Hepatocyte growth factor-scatter factor: mitogen, motogen and Met. Cancer Cells 3: 227-232, 1991.
7. Wang Y, Selden AC, Morgan N, Stamp GWH and Hodgson HJF: Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 144: 675-682, 1994.
8. Seslar S, Nakamura T and Byers S: Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-β activation. Endocrinology 136: 1945-1953, 1995.
9. Oda Y, Sakamoto A, Saito T, Kinukawa N, Iwamoto Y and Tsuneyoshi M: Expression of hepatocyte growth factor (HGF)/ scatter factor and its receptor c-Met correlates with a poor prognosis in synovial sarcoma. Hum Pathol 31: 185-192, 2000.
10. Di Renzo MF, Olivero M, Martone T, Maffe A, Maggiora P, De Stefani A, Valente G, Giordano S, Cortesina G and Comoglio PM: Somatic mutations of the c-Met oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 19: 1547-1555, 2000.
11. Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID and Rosen EM: Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17: 131-141, 1998.
12. Klominek J, Baskin B, Liu Z and Hauzenberger D: Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer 76: 240-246, 1996.
13. Thirkettle I, Harvey P, Hasleton PS, Ball RY and Warn RM: Immunoreactivity for cadherins, HGF/SF, met and erbB-2 in pleural malignant mesotheliomas. Histopathology 36: 522-528, 2000.
14. Zimmerman RL, Fogt F and Goonewardene S: Diagnostic value of a second generation CA15-3 antibody to detect adenocarcinoma in body cavity effusions. Cancer Cytopathol 90: 230-234, 2001.
15. Zimmerman RL, Fogt F and Goonewardene S: Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions. Anal Quant Cytol Histol 22: 353-357, 2000.
16. Zimmerman RL: The FHIT protein is expressed in benign mesothelium and has no clinical value in detecting carcinoma in body cavity effusions. Appl Immunohistochem Mol Morph 8: 154-157, 2000.
17. Braunschweig R, Yan P, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A and Benhattar J: Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 24: 174-180, 2001.
18. Saha I, Dey P, Vhora H and Nijhawan R: Role of DNA flow cytometry and image analysis on effusion fluid. Diagn Cytopathol 22: 81-85, 2000.
19. Garcia-Pratts MD, Ballestin C, Sotelo T, Lopez-Encuentra A and Mayordomo JI: A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumors. Histopathology 32: 462-472, 1998.
20. Dejmek A, Brockstedt U and Hjerpe A: Optimsization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesotheliomas and adenocarcinoma. APMIS 105: 889-894, 1997.
21. Ordóñez NG: Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 22: 1203-1214, 1998.
22. Michalopoulos GK and Zarnegar R: Hepatocyte growth factor. Hepatology 15: 149-155, 1992.
23. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T and Nakano H: The prognostic significance of amplification and overexpression of c-Met and c-erb B-2 in human gastric carcinomas. Cancer 85: 1894-1902, 1999.
24. Nakopoulou L, Gakiopoulou H, Keramopoulos A, Giannopoulou I, Athanassiadou P, Mavrommatis J and Davaris PS: c-met tyrosine kinase receptor expression is associated with abnormal β-catenin expression and favorable prognostic factors in invasive breast carcinoma. Histopathology 36: 313-325, 2000.
25. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID and Rosen EM: Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79: 749-760, 1997.
26. Yamashita JI, Ogawa M, Yamashita SI, Nomura K, Kuramoto M, Saishoji T and Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence in human breast carcinoma. Cancer Res 54: 1630-1633, 1994.
27. Huntsman D, Resau JH, Klineberg E and Auersperg N: Comparison of c-Met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy. Am J Pathol 155: 343-348, 1999.